Fundz

Micro Vascular Tissues reported raising $4.11 Million in an initial SEC Form D filing, from an offering of $6.1 Million

PRIVATEMar 10, 2023

Amount Raised

$4.11 Million

$4.11 Million sold, per SEC Form D (first sale Feb 23, 2023)

Round Type

Seed

Jamaica PlainHealthcare

Who to call at MicroVascular Tissues, and when

A new round usually means MicroVascular Tissues is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MicroVascular Tissues raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MicroVascular Tissues, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MicroVascular Tissues. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MicroVascular Tissues

Location

60 Orchard Street

Jamaica Plain, Massachusetts, United States

About

Microvascular Tissues, Inc. (MVT) is an evidence-based regenerative medicine company developing and commercializing products that address vascular deficiencies using vascular solutions, including mVASC®, an allogeneic structural microvascular tissue graft.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MicroVascular Tissues raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at MicroVascular Tissues. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MicroVascular Tissues's next move

See what Strategic adds

MicroVascular Tissues raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.